that_ginger_one to United KingdomEnglish · 1 year agoExperts urge health regulators to approve 2 ‘turning point’ dementia drugs; donanemab & lecanemab.www.theguardian.comexternal-linkmessage-square0fedilinkarrow-up120arrow-down10
arrow-up120arrow-down1external-linkExperts urge health regulators to approve 2 ‘turning point’ dementia drugs; donanemab & lecanemab.www.theguardian.comthat_ginger_one to United KingdomEnglish · 1 year agomessage-square0fedilink